Panbela to Present at the LD Micro Investor Conference
MINNEAPOLIS, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced today that management will be presenting at the LD Micro Conference on Wednesday, October 4, 2023, at 3:30pm PT. The presentation will be streamed live and available for replay at: https://me23.sequireevents.com/ .
For more information about the conference or to schedule a one-on-one in person meeting with management contact your conference representative or email [email protected].
About our Pipeline
Cautionary Statement Regarding Forward-Looking Statements
Using Content-Based Analytics to Mitigate Adverse Call Labeling of Legitimate Enterprise Communications
Imagine A World Without Hold Times â€“ An AI Optimist Explains
Keynote Panel: The Continued Rise of AI: Embracing the Known and Unknown to Drive Business Results